ExeVir Bio

Antibodies attack Covid-19
#Antibodies #Covid variants #Covid-19 #Covid-19 treatment #ExeVir Bio #Omicron

Antibody cocktail effective against emerging Covid-19 variants

Biotech company ExeVir Bio has revealed new data demonstrating that its antibodies are effective in neutralising currently circulating Covid-19 Omicron variants. The company says that all authorised SARS-CoV-2 therapeutic antibodies that have been used in the clinic show severe to complete loss of virus neutralisation potency… Read More

#News